0.4993

15.34% -0.0905

Heartbeam Inc (BEAT)

Overview News Price History Financials Discussions Forecast

Heartbeam Inc stock is traded at $0.4993, with a volume of 1.08M. It is down -15.34% in the last 24 hours and down -10.97% over the past month. HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.

Previous Close:

$0.5898

Open:

$0.56

24h Volume:

1.08M

Relative Volume:

1.41

Market Cap:

$27.71M

Revenue:

Net Income/Loss:

$-20.23M

P/E Ratio:

-0.8888

EPS:

-0.5618

Net Cash Flow:

$-13.97M

1W Performance:

-4.66%

1M Performance:

-10.97%

6M Performance:

-62.46%

1Y Performance:

-55.02%

1-Day Range:

$0.4913

$0.585

1-Week Range:

$0.4913

$0.6278

52-Week Range:

$0.4813

$4.00

Heartbeam Inc Stock (BEAT) Company Profile

Name

Heartbeam Inc

Sector

Healthcare (1080)

Industry

Health Information Services (47)

Phone

408-899-4443

Address

2118 WALSH AVE., SUITE 210, SANTA CLARA

Employee

Twitter

Next Earnings Date

2026-08-13

Latest SEC Filings

BEAT's Discussions on Twitter

Compare BEAT vs VEEV, BTSG, TEM, HQY, TXG

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BEAT Heartbeam Inc	0.4993	31.75M	0	-20.23M	-13.97M	-0.5618
VEEV Veeva Systems Inc	243.75	39.23B	3.32B	941.65M	1.64B	5.6161
BTSG Brightspring Health Services Inc	61.71	11.81B	13.65B	169.86M	412.12M	1.0758
TEM Tempus Ai Inc	52.10	9.85B	1.36B	-302.91M	-219.93M	-1.7182
HQY Healthequity Inc	104.73	8.82B	1.34B	230.70M	440.96M	2.6695
TXG 10 X Genomics Inc	56.09	7.52B	638.78M	-22.66M	122.18M	-0.1744

Heartbeam Inc Stock (BEAT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-20-26	Downgrade	D. Boral Capital	Buy → Hold
Mar-31-26	Initiated	B. Riley Securities	Buy
Mar-27-26	Initiated	D. Boral Capital	Buy
Mar-16-26	Downgrade	The Benchmark Company	Buy → Speculative Buy
Dec-11-25	Upgrade	The Benchmark Company	Speculative Buy → Buy
Dec-08-25	Initiated	H.C. Wainwright	Buy
Oct-31-25	Initiated	Roth Capital	Buy
Sep-11-20	Initiated	Needham	Buy
Sep-02-20	Initiated	Robert W. Baird	Neutral
Jan-08-20	Initiated	SunTrust	Buy
Aug-02-19	Downgrade	Raymond James	Outperform → Mkt Perform
Apr-26-19	Reiterated	Dougherty & Company	Buy
Jul-26-18	Reiterated	Lake Street	Buy
Apr-26-18	Reiterated	The Benchmark Company	Buy
Feb-23-18	Reiterated	Dougherty & Company	Buy
Nov-08-17	Reiterated	Dougherty & Company	Buy
Oct-26-17	Initiated	Raymond James	Outperform
Oct-24-17	Initiated	SunTrust	Buy
Aug-09-17	Reiterated	Dougherty & Company	Buy
Jul-19-17	Reiterated	The Benchmark Company	Buy
Apr-11-17	Reiterated	Dougherty & Company	Buy
Dec-02-16	Initiated	Dougherty & Company	Buy
Sep-13-16	Initiated	Sidoti	Buy
Aug-03-16	Reiterated	The Benchmark Company	Buy
Jul-28-15	Reiterated	Dougherty & Company	Buy
Oct-24-13	Initiated	The Benchmark Company	Buy
Aug-21-13	Initiated	Dougherty & Company	Buy

View All

Heartbeam Inc Stock (BEAT) Latest News

Aug 14, 2026

HeartBeam enters $25 million at-the-market equity sales agreement with Titan Partners - Investing.com Canada

Aug 14, 2026

Heartbeam, Inc. Enters Into At-The-Market Equity Offering Sales Agreement For Up To $25 Million In Common Stock - TradingView

Aug 14, 2026

Form 8K Heartbeam Inc For: 14 August By Investing.com - Investing.com India

Aug 14, 2026

Medical Journal Article Highlights Technology’s Potential to Detect Heart Attack Risk at Home - Medical Product Outsourcing

Aug 14, 2026